Lymphocyte responsiveness to glucocorticoids, cyclosporine, or both

Journal of Clinical Pharmacology

Volumn 36, Issue 8, 1996, Pages 707-714

  Briggs, William A ^a   Gao, Zu Hua ^a   Gimenez, Luis F ^a   Scheel Jr , Paul J ^a   Choi, Michael J ^a   Burdick, James F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG RESPONSE; FEMALE; GLOMERULOPATHY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MALE;

EID: 0029817889     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04239.x     Document Type: Article

References (44)

1. Cameron JS: The long-term outcome of glomerular diseases. In, Shrier RW. Gottshalk CW (eds.): Diseases of the Kidney. Boston, MA: Little Brown. 1988;2127-2189.
2. Briggs W, Gao Z-H, Scheel P, Burdick J, Gimenez L, Choi MI: Differential in vitro lymphocyte glucocorticoid responsiveness in dialysis patients (abstract). J Am Soc Nephrol 1995;6:522.
3. Kraft N, Atkins RC, Thomson MM: Differential susceptibility in vitro to methylprednisolone of human lymphocyte subpopulations stimulated by phytohemagglutinin. Transplant Proc 1979;11:1375-1376.
4. Walker KB, Potter JM, House AK: Variable inhibition of mitogen-induced blastogenesis in human lymphocyte by prednisolone in vitro. Transplant Proc 1985;17:1676-1678.
5. House AK, Potter JM, Walker KB: Prednisolone and rejection: suppressed lymphocyte blastogenesis and allograft rejection. Transplant Proc 1986;18:211-214.
6. Langhoff E, Jakobsen BK, Ryder LP, Ladefoged J, Platz P, Svejgaard A, Thayson JH: Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet 1986;1: 1286-1297.
7. Langhoff E, Ladefoged J: The impact of high lymphocyte sensitivity to glucocorticoids on kidney graft survival in patients treated with azathioprine and cyclosporine. Transplantation 1987;43:380-384.
8. Francis DMA, Dumble LT, Bowes L, Clunie GJA, MacDonald IM: Adverse influence of recipient lymphoid resistance to in vitro immunosuppression on the outcome of kidney transplants. Transplantation 1988;46:853-857.
9. Pollak R, Dumble LJ, Lazda VA, Maddux MS, Stormoen B, Ward M: Utility of an in vitro immunoassay to guide immunosuppressive therapy. Transplant Proc 1991;23:1113-1114.
10. Kang X-X, Hirano T, Oka K, Sakurai E, Tamaki T, Kozaki M: Role of altered prednisolone-specific lymphocyte sensitivity in chronic renal failure as a pharmacodynamic marker of acute allograft rejection after kidney transplantation. Eur J Clin Pharmacol 1991;41:417-423.
11. Hirano T, Oka K, Takeuchi H, Sakurai E, Matsuno N, Tamaki T, Kozaki M: Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation: marked difference between prednisolone and methylprednisolone. Transplantation 1994;57:1341-1348.
12. Kirkam BW, Corkill MM, Davison SC, Panayi GS: Response to glucocorticoid treatment in rheumatoid arthritis: in vitro mediated immune assay predicts in vivo responses. J Rheumatol 1991;18:821-825.
13. Poznansky MC, Gordon ACH, Douglas JG, Krajewski AS, Wyllie AH, Grant IWB: Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci (London) 1984;67:639-645.
14. Lagrue G, Laurent J, Belghiti D, Robeva R: Cyclosporine and idiopathic nephrotic syndrome. Lancet 1986;2:692-693.
15. Maher ER, Sweny P, Chappel M, Varghese Z, Morhead JE: Cyclosporine in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Nephrol Dial Transplant 1988;3:728-732.
16. Meyrier A. Collaborative Group of the Societe de Nephrologie: Cyclosporin in the treatment of nephrosis. Am J Nephrol 1989;9 (suppl):S65-S71.
17. Walker RG, Kincaid-Smith P: The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with cyclosporin. Nephron 1990;54:117-121.
18. Niaudet P for the French Society of Pediatric Nephrology: Cyclosporine and steroid resistant idiopathic nephrotic syndrome in children (abstract). J Am Soc Nephrol 1992;3:326.
19. Melocoton TL, Kamil ES, Cohen AH, Fine RN: Long-term cyclosporin A treatment in steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 1991;18:583-588.
20. Niaudet P, Broyer M, Habib R: Treatment of idiopathic nephrotic syndrome with cyslosporin A in children. Clin Nephrol 1991;35:S31-S36.
21. DeSanto NG, Capodicasa G, Giordano C: Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin. Am J Nephrol 1987;7: 74-76.
22. Lai KN, Lai FM, Li PKT, Vallance-Owen J: Cyclosporine treatment of IgA nephropathy: a short-term controlled trial. BMJ 1988;295:1165-1168.
23. Favre H, Miescher POA, Huang YP, Chatelanat F, Mihatsch MJ: Cyclosporin in the treatment of lupus nephritis. Am J Nephrol 1989;9:S57-S60.
24. Cattran DC: Current status of cyclosporin A in the treatment of membranous, IgA and membranoproliferative glomerulonephritis. Clin Nephrol 1991;35:S43-S47.
25. Rostoker G, Belghiti D, Ben Maadi A, Remy P, Lang P, Weil B, Lagrue G: Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 1993;63:335-341.
26. Niaudet P, Habib R: Cyclosporine in the treatment of idiopathic nephrotic syndrome. J Am Soc Nephrol 1994;5:1049-1056.
27. Hayes M, Alam AFMS, Bruckner FE, Doherty SM, Myles A, English J, et al: Plasma prednisolone studies in rheumatic patients. Ann Rheum Dis 1983;42:151-154.
28. Jusko WJ: Corticosteroid pharmacodynamics: models for a broad array of receptor-mediated pharmacologie effects. J Clin Pharmacol 1990;30:303-310.
29. Langhoff E, Hvidberg EF, Flachs H, Ladefoged J: Glucocorticoid levels and lymphocyte functions in kidney transplanted patients. Pharmacol Toxicol 1987;60:269-273.
30. Ost L, Bjorkhem I, von Bahr C: Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation. Eur J Clin Pharmacol 1984;133:363-369.
31. Frey BM, Frey WFJ, deWeck AL: Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 1984;133: 2479-2487.
32. Tornatore KM, Reed K, Walshe JJ, Venuto RC: Cortisol pharmacodynamic response to long-term methylprednisolone in renal transplant recipients. Pharmacotherapy 1984;14:111-118.
33. Tornatore KM, Reed KA, Venuto RC: Repeated assessment of methylprednisolone pharmacokinetics during chronic immunosuppression in renal transplant recipients. Ann Pharmacother 1995;29:120-124.
34. Tornatore KM, Biocevich DM, Reed K, Tousley K, Singh JP, Venuto RC: Methylprednisolone pharmacokinetics, cortisol response and adverse effects in black and white renal transplant recipients. Transplantation 1985;59:729-736.
35. Lindholm A, Kahan BD: Influence of Cyclosporine pharmacokinetics, through concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993;54: 205-218.
36. Fluckiger SS, Schmidt C, Meyer A, Kallay Z, Johnston A, Kutz K: Pharmacokinetics of orally administered cyclosporine in patients with Crohn's disease. J Clin Pharmacol 1995;35:681-687.
37. Tan KKC, Trull AK, Uttridge JA, Metcalfe S, Heyes CS, Facey S. Evans DB: Effect of dietary fat on the pharmacokinetics and pharmacodynamics of Cyclosporine in kidney transplant recipients. Clin Pharmacol Ther 1995;57:425-433.
38. Langhoff E, Ladefoged J: Relative immunosuppressive potency of various corticosteroids measured in vitro. Eur J Clin Pharmacol 1983;25:459-462.
39. Langhoff E, Olgaard K, Ladefoged J: The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures. Int J Immunopharmacol 1987;9:469-473.
40. Derendorf H, Hochhaus G, Mollmann H, Barth J, Krieg M, Sabine T, Mollmann C: Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol 1993;33: 115-123.
41. van Rigthoven AW, Dykmans BA, Goeithe HA, Boers M, Cats A: Long-term cyclosporine therapy in rheumatoid arthritis. J Rheumatol 1991;18:19-23.
42. Hodgson HJF: Cyclosporin in inflammatory bowel disease. Aliment Pharmacol Ther 1991;5:343-350.
43. Deray G, Benhmida M, Hoang PL, Maksud P, Aupetit B, Baumelou A, Jacobs C: Renal function and blood pressure in patients receiving long-term, low dose cyclosporine therapy for idiopathic autoimmune uveitis. Ann Intern Med 1992;117:578-583.
44. Corrigan CJ, Brown PH, Barnes NC, Tsai J-J, Frew AJ, Kay AB: Glucocorticoid resistance in chronic asthma: peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporine A. Am Rev Respir Dis 1991;144:1026-1032.